Development of the bicyclic mid-size peptide KS-133 as a VIPR2-specific antagonist and its antitumor effect through modulation of macrophage polarity

○Kotaro Sakamoto

Presentation information

Poster Presentation

(A) Pharmaceutical Chemistry

[29P-pm] Synthetic compounds in drug discovery/Natural medicines and biological products/Middle-molecule drugs

Fri. Mar 29, 2024 1:30 PM - 5:00 PM [Poster] Exhibition Hall AB (1F)

[29P-pm111] Development of the bicyclic mid-size peptide KS-133 as a VIPR2-specific antagonist and its antitumor effect through modulation of macrophage polarity

○Kotaro Sakamoto¹, Eijiro Miyako², Shinsaku Nakagawa³, Yukio Ago⁴, Akira Nishiyama⁵ (1. Ichimaru Pharcos co. Ltd., 2. JAIST, 3. Osaka Univ., 4. Hiroshima Univ., 5. Kagawa Univ.)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[29P-pm] Synthetic compounds in drug discovery/Natural medicines and biological products/Middle-molecule drugs

[29P-pm111] Development of the bicyclic mid-size peptide KS-133 as a VIPR2-specific antagonist and its antitumor effect through modulation of macrophage polarity

Password